AstraZeneca PLC American Depositary Shares (AZN)
NASDAQ (NGS) NASDAQ (NGS) Primary 
AstraZeneca slides after confirming five employees held by China police
AstraZeneca PLC (LSE:AZN) shares fell 3.5% after it confirmed that five current and former employees in China are being held by police for questioning. The individuals, all Chinese nationals, worked in the company's oncology division marketing cancer treatments, with the police detentions made in the city of Shenzhen earlier this summer.
AstraZeneca says staff detained in China amid reports of a drug-import investigation
Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the company confirmed Thursday. "We are aware a small number of our employees in China are under investigation and we have no further information to share at this point," an AstraZeneca spokesperson told CNBC by email.
AstraZeneca confirms five employees held by China police
AstraZeneca PLC (LSE:AZN) has confirmed that five current and former employees in China are being held by police for questioning. The individuals, all Chinese nationals, worked in the company's oncology division marketing cancer treatments, with the police detentions made in the city of Shenzhen earlier this summer.
China detains AstraZeneca staff in data, drug-import probes, Bloomberg News reports
The police in China have detained five current and former employees of AstraZeneca for questioning about potential illegal activities, Bloomberg News reported on Thursday, citing people familiar with the matter.
Nvidia whacked for $270bn as economic, AI concerns mount
Nvidia Corp's volatile nature was on full display when its share price fell nearly 10% before the closing bell on Tuesday. It meant a record $270 billion was stripped from the artificial intelligence microchip maker's market value- that's more than the entire market capitalisation of Britain's largest company AstraZeneca PLC (LSE:AZN).
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
QGEN's expanded collaboration with AstraZeneca to focus on developing companion diagnostics beyond oncology.
AstraZeneca share price has gone vertical; brace for a pullback
AstraZeneca (LON: AZN) share price is firing on all cylinders as it sits on its all-time high. It has soared in the last five consecutive weeks, the longest streak since April 2023.
AstraZeneca (AZN) Denies Rumors About UK Facility Relocation
Per third-party reports, AstraZeneca (AZN) has refuted rumors about considering a change in the relocation of a vaccine manufacturing plant from the U.K. to the United States.
Rumours of AstraZeneca relocating vaccine ops to US ‘untrue'
British biotech giant AstraZeneca PLC (LSE:AZN) has rebuffed claims that it is moving its vaccine operations to the US. A Financial Times report suggested that AstraZeneca could relocate its vaccine manufacturing operations to Philadelphia due to the Labour government' plans to cut state aid.
AstraZeneca warns of moving UK vaccine production to US, FT reports
AstraZeneca has warned it could relocate its vaccine manufacturing site from the UK to the U.S. amid a deadlock in negotiations with the Labour government over plans to cut state aid promised to the project, the Financial Times reported on Thursday.
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung Cancer
This approval is based on late-stage study data, which shows that treatment with AstraZeneca's (AZN) Imfinzi reduced the risk of recurrence by 32% in certain non-small cell lung cancer patients.
AstraZeneca receives another US approval for cancer drug Imfinzi
AstraZeneca PLC's (LSE:AZN) blockbuster immunotherapy cancer drug Imfinzi (durvalumab) has received another approval in the US. In combination with chemotherapy, patients suffering resectable early-stage (IIA-IIIB) non-small cell lung cancer (NSCLC) can now receive Imfinzi before and after surgery.
